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Impact of carotid atherosclerosis on long-term mortality in
chronic hemodialysis patients.
Background. Cardiovascular event is the major cause of mor-
tality in patients on maintenance hemodialysis. We prospec-
tively tested the predictive values of atherosclerotic parameters
for all-cause and cardiovascular outcomes in 219 hemodialysis
patients (age, 58  13 years; time on hemodialysis, 13  7
years; male/female, 144/75).
Methods. We measured blood homocysteine (Hcy), ultra-
sound carotid artery intima media thickness (IMT) and %
aortic wall calcification at L2/3 region [% of calcification index
in the abdominal aortic wall (%ACI)] by computed tomogra-
phy (CT) scan, and followed all patients for 5 years.
Results. During the follow-up periods, 54 patients (25%)
died, 40 (74%) of them of cardiovascular causes. IMT was
significantly higher in patients who expired (0.75  0.02 mm)
than in those who survived (0.62  0.01 mm). IMT was signifi-
cantly correlated with age (r 0.47, P 0.01) and %ACI (r
0.27, P  0.01). The survival rate during the observation was
significantly lower in the final IMT third (58%) than in the
first (90%) and the middle IMT third (80%) (P 0.01). Multi-
variate Cox proportional hazards analysis revealed that diabe-
tes and IMT became independent determinants of all-cause
and cardiovascular death. Adjusted hazards ratios of all-cause
and cardiovascular mortality for an increase of 0.1 mm in IMT
were 1.31 (95% CI, 1.07 to 1.59) and 1.41 (95% CI, 1.12 to
1.76). In contrast, %ACI at abdominal aorta and blood Hcy
did not affect their 5-year mortality.
Conclusion. These findings suggested that measurement of
carotid artery IMT is useful for predicting long-term mortality
in patients receiving maintenance hemodialysis.
Atherosclerotic cardiovascular disease is the major cause
of mortality and morbidity in hemodialysis patients.
B-mode ultrasound imaging is a useful and noninvasive
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tool to directly quantitate the atherosclerotic burden [1, 2].
Hemodialysis patients are known to have an advanced
carotid artery intima medial thickness (IMT) compared
with age- and gender-matched normal subjects [3]. Cal-
cified plaque is also common in carotid arteries of hemo-
dialysis subjects without clinical vascular disease [4]. Re-
cently, a marked increment of carotid artery IMT is noted
in predialysis renal failure patients [5, 6]. End-stage renal
failure itself, but not classical cardiovascular risk, is dem-
onstrated as an independent predictor of arterial IMT
[6]. Increased IMT, arterial stiffness, and coronary artery
calcification are also noted in young adults on regular
hemodialysis [7–9]. These findings suggest that uremia
and/or metabolic disorder due to end-stage renal failure
may be to a greater extent associated with accelerated
atherosclerosis in dialysis subjects.
There still is a debate, however, as to whether IMT
reflects local atherosclerosis or rather simple arterioscle-
rosis. IMT consists mainly of media and a small amount
of intima, whereas atherosclerosis is an intimal process.
Epidemiologic studies have shown that increases in ca-
rotid artery IMT are associated with risk of myocardial
infarction and stroke in general subjects [1, 10]. In con-
trast, other studies rather demonstrate a better correla-
tion of plaque diameter measurement than IMT with
atherosclerotic events [11, 12]. Thus, it remains unclear
as to whether carotid artery IMT is much useful for
predicting long-term cardiovascular outcomes.
The main aim of the present study is to ascertain the
clinical relevance of carotid artery IMT for cardiovascu-
lar and all-cause mortality in patients receiving regular
hemodialysis. We cross-sectionally measured ultrasound
IMT and vascular plaque of bilateral common carotid
arteries. We also assessed abdominal aortic wall calcifica-
tion by computed tomography (CT) scan, which has been
validated as a predictor of cardiovascular morbidity and
mortality in general population. After determining these
parameters, we followed the patients for next 5 years.
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METHODS
Study population
We selected stable 219 out of 348 patients from a
single dialysis unit (Maruyama Hospital, Hamamatsu,
Japan) at August 1997. We excluded outpatients who
denied participating in this study because of their time
limitations (N  98). Hospitalized subjects who compli-
cated by acute infection, congestive heart failure (CHF),
severe dialysis-related amyloidosis, and malignancies
were not enrolled (N  28). We also excluded subjects
who had active collagen vascular diseases such as rheu-
matoid arthritis (N  3). The patients comprised 144
males and 75 females with a mean age of 58  13 years
(range, 25 to 96 years). The mean time on hemodialysis
was 13  7 years (range, 1 to 28 years). There were 35
diabetic patients (16%). Eleven persons had a history of
cardiovascular events such as cerebral infarction, CHF,
angina, and acute myocardial infarction (AMI) at the
assessment. The lifelong dose of smoking was calculated
as Brickman index (BI), a product of years of smoking
history and daily number of cigarettes.
Hemodialysis-related factors
All patients had been subjected to regular hemodialy-
sis for 4 to 5 hours three times per week at a blood flow
rate of 180 to 220 mL/min. All patients used bicarbonate
dialysate (30 mEq/L) (Kindaly AF-2P, Fuso, Osaka, Ja-
pan) at a flow rate of 500 mL/min. All hemodialysis
treatments were performed using one of the following
dialyzer membranes: low-flux ultrafiltration rate (UFR)
(20 mL/min · hour), modified regenerated cellulose
hollow-fiber (MRC) (AM-BC, Asahi Medical, Tokyo,
Japan, or CL-EE, Terumo, Tokyo, Japan), medium-flux
UFR (20 to 40 mL/min · hour), cellulose triacetate hol-
low-fiber (CTA) (FB-U, Nipro Medical, Osaka, Japan
or TFW, Teijin-Gambro, Tokyo, Japan), and high-flux
UFR (40 mL/min · hour) polysulfone synthetic hollow-
fiber (BS-U, Toray Medical, Tokyo, Japan or APA,
Asahi Medical, Tokyo, Japan). There was no patient
who reused the dialyzer membrane. Neither bacteria nor
pyrogen was detected in the dialysate prepared from
water obtained by reverse osmosis. Blood samples were
drawn from the arterial site of the arteriovenous fistula
at the beginning and the end of the hemodialysis unit.
Serum or plasma was transferred into plastic tubes and
stored until –82C until the measurement. Serum urea
nitrogen, creatinine, total protein, albumin, total choles-
terol, high-density lipoprotein (HDL) cholesterol and
hemoglobin were measured by standard laboratory tech-
niques using automatic analyzer. Intact parathyroid hor-
mone (PTH) was determined using immunoradiometric
assay. C-reactive protein (CRP) was determined by laser
nephrometer. Plasma total homocysteine (Hcy) was de-
termined by a high-pressure liquid chromatography based
on a derivative of SBD-F fluorescence. The efficiency of
hemodialysis was assessed based on the delivered dose of
dialysis (Kt/Vurea) using a single-pool urea kinetic model.
Evaluation of atherosclerotic changes
The right and left carotid arteries were examined using
a 7.5 Hz linear array transducer with high-resolution
B-mode echography (Aloka, Tokyo, Japan) as described
previously [13]. This device can measure the arterial wall
thickness by 0.1 mm. The subjects were in the supine
position with the head slightly turned from echography
at the measurement. All scannings were performed by
the same investigator. The wall of the common carotid
artery, 0.5 to 1.0 cm proximal to the beginning of the
carotid bulb, was used for the measurement of the IMT
and lumen diameter. The IMT was defined as the dis-
tance between the leading edge of the lumen intima
echo of the near wall and the leading edge of the media
adventitia echo. The lumen diameter was defined as the
distance between the leading edge of the intima lumen
echo of the near wall and the leading edge of the lumen
intima echo of the far wall. To enhance the reproducibility
of carotid measures, standardized interrogation angles
were used. The mean values of the IMT and lumen diame-
ter were calculated from at least two measurements for
each artery. IMT measurements were always performed
in plaque-free arterial segments. The intraobserver coef-
ficient of variation in all of the patients was 6.0% (mean
difference, 0.02 mm). We also measured carotid artery
IMTs in six portions from healthy subjects by a blind
observer, and found 9.2% of coefficient of variation (mean
difference 0.03 mm). The existence of carotid plaque,
which is defined as the intima media thickening of more
than 1 mm, was screened for in the common, internal,
and external carotid arteries. We measured the maximal
diameter of carotid plaque along the artery wall.
Electrocardiogram (ECG) was recorded just before
the starting of dialysis. The presence of abnormal Q or
inverted T wave in extremity leads was defined as isch-
emic ECG changes. The percentile of calcification index
in the abdominal aortic wall (%ACI) was measured at
the horizontal CT slice between the second and third
lumbar vertebrae, since calcific deposit was most remark-
able in this region [14].
The predialysis mean blood pressure (MBP) was de-
termined as MBP  diastolic  (systolic – diastolic)/3.
Atherosclerotic index (AI) was calculated as AI (total
cholesterol – HDL cholesterol)/HDL cholesterol [15].
Low-density lipoprotein (LDL) cholesterol was calcu-
lated from modified Friedewald’s formula for Japanese
population (total cholesterol – HDL cholesterol – triglycer-
ide/4) [16].
5-Year follow-up study
After the determination of initial laboratory and ath-
erogenic parameters, we followed all patients for 5 years
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Fig. 1. Association between carotid artery in-
tima media thickness (IMT) and blood albu-
min and C-reactive protein (CRP) in hemodi-
alysis patients. A significant relationship was
found between carotid artery IMT and albu-
min (r  0.23, P  0.01) (A) and CRP (r 
0.39, P  0.01) (B ).
until August 2002. No patient was lost to follow-up. Each
death was reviewed and assigned an underlying cause
by three physicians. Cardiovascular mortality included
death from stroke, AMI, and CHF. We divided all sub-
jects into surviving and expired groups and evaluated
the influence of these parameters on mortality.
Statistical analysis
Each value was expressed as the mean  SD. Differ-
ences between two groups were analyzed by an unpaired
Student t test following the analysis of variance (ANOVA)
method. P values less than 0.05 were considered statisti-
cally significant. Kaplan-Meier estimates of IMT and
intact PTH were calculated for the time of death during
follow-up. The P values for comparison of survival curves
were determined by the log-rank test. The relative risk
of different parameters was estimated using the Cox
proportional hazards model. Relative risks (RR) and
their 95% confidence intervals (95% CI) were calculated
using the estimated regression coefficients and their stan-
dard error in the Cox regression analysis. We evaluated
17 parameters: age, gender, time on hemodialysis, diabe-
tes mellitus, serum albumin, hemoglobin, the product of
calcium and phosphate, total cholesterol, AI, Hcy, BI,
Kt/Vurea, intact PTH, CRP, carotid artery IMT, plaque,
and %ACI as a univariate model. In addition, chi-square
statistics were obtained. The independent effect of each
explanatory variable on log carotid artery IMT was as-
sessed using forward stepwise multiple regression analy-
sis with five associated variables, including age, albumin,
total cholesterol, log CRP and BI. Since IMT and CRP
were nonnormally distributed, we normalized these data
by log transformation, and examined their correlations.
All statistical calculations were performed with the Stat-
View 5J software (SAS Institute, Inc., Cary, NC, USA).
RESULTS
Clinical data and atherogenic parameters
There was a significant and positive relationship be-
tween age and carotid artery IMT (r  0.47, P  0.01)
and %ACI at L2/3 region (r  0.41, P  0.01). In con-
trast, gender, seropositivity of antihepatitis C antibody,
and time on hemodialysis were not associated with these
two parameters. No significant difference was found in
carotid artery IMT between diabetic (0.71  0.18 mm)
and nondiabetic patients (0.64  0.15 mm). However,
the prevalence of carotid artery plaque was significantly
higher in diabetic subjects (54% vs. 33%, P  0.02).
Diabetic patients also had a significantly higher %ACI
than nondiabetic patients (50.4  29.3% vs. 22.7 
22.7%, P  0.01).
Blood albumin was significantly and inversely corre-
lated with carotid artery IMT (r 0.23, P 0.01, Fig. 1),
but not with %ACI. Albumin was also significantly asso-
ciated with log-transferred IMT (r  0.25, P  0.01).
Similarly, IMT was positively correlated with CRP (r 
0.39, P 0.01, Fig. 1). A significant and positive relation-
ship between IMT and CRP was also observed following
log transformation (r  0.32, P  0.01). There was a
weak but significant and positive relationship between
log IMT and BI in habitual smoking subjects (r  0.21,
P 0.05, N 96). Total cholesterol was also significantly
and inversely correlated with log IMT (r  0.17, P 
0.02). In contrast, plasma Hcy, LDL cholesterol, and
blood pressure were not associated with carotid artery
IMT or %ACI. Dialyzer membrane also did not influ-
ence mean IMT. There was no association between
%ACI and the product of calcium and phosphate, blood
pressure, or intact PTH in this study. A stepwise multiple
regression analysis revealed that age and total choles-
terol became significant determinants of IMT.
A significant increase in carotid artery IMT was found
in hemodialysis patients possessing ischemic ECG changes
(0.70  0.18 mm, N  96) compared with those without
ischemic ECG changes (0.61  0.12 mm, N  116) (P 
0.01). The prevalence of carotid plaque was also higher
in patients having ischemic ECG changes (47% vs. 29%,
P  0.01). A weak but significant and positive relation-
ship was found between IMT and %ACI (r  0.27, P 
0.01).
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Table 1. Initial clinical parameters in surviving and expired
hemodialysis patients
Alive Dead P value
Number 165 54
Age years 5611 [26–87] 6514 [25–96] 0.01
Male/female 112/53 32/22 0.25
Time on hemodialysis
treatment years 137 [1–28] 128 [3–25] 0.47
Prevalence of diabetes % 9.7 35.2 0.01
HCV infection % 27.6 25.0 0.85
Dialysis-related factors
Calcium mEq/L 4.60.4 4.50.5 0.36
Phosphate mg/dL 6.01.6 5.51.9 0.06
Product of calcium and
phosphate 27.78.0 24.99.5 0.05
Intact PTH pg/mL 207254 3671011 0.06
Hemoglobin g/dL 10.01.1 9.91.2 0.49
Kt/Vurea 1.250.24 1.330.19 0.34
PS membrane % 44.6 32.2 0.16
Nutrition-related factors
Albumin g/dL 4.00.3 3.80.4 0.01
Triglyceride mg/mL 13474 11997 0.27
Total cholesterol mg/dL 15533 14427 0.05
BMI kg/m2 21.32.7 20.81.8 0.68
CRP mg/dL 0.350.42 0.460.57 0.45
Atherosclerotic risk factors
Blood pressure mm Hg
Systolic 14022 14821 0.06
Diastolic 7513 7414 0.84
Mean 10816 11117 0.23
Smoking % 47.8 68.2 0.87
Brickman index in
smokers 440348 630641 0.08
HDL cholesterol mg/dL 3510 3310 0.41
LDL cholesterol mg/dL 8729 8226 0.26
Atherogenic index 4.00.3 3.80.4 0.64
Homocysteine lmol/L 37.424.3 34.019.5 0.36
Atherosclerotic parameters
Carotid artery IMT mm 0.620.14 0.750.18 0.01
Prevalence of plaque % 32.1 50.0 0.02
Maximal plaque
diameter mm 3.21.6 3.41.9 0.71
% ACI at L2/3 24.424.4 33.228.1 0.09
Ischemic ECG change % 35.8 76.0 0.01
Abbreviations are: HCV, hepatitis C virus; PTH, parathyroid hormone; PS,
polysulfone; BMI, body mass index; CRP, C-reactive protein; %ACI, % aortic
calcification index; ECG, electrocardiogram. Data are expressed as mean  SD.
Clinical parameters and the 5-year mortality
Fifty-four patients (25%) died during the 5-year fol-
low-up (male/female, 32/22). The causes of death were
cardiovascular events in 40 (74%), pulmonary infection
in eight (15%), gastrointestinal bleeding in two (4%),
and other causes in four patients (7%). Cardiovascular
fatal events consisted of CHF in 23, AMI in 11, and
stroke in six deaths. Dead patients were significantly
older than surviving subjects (P 0.01), but there was no
difference in time on hemodialysis between two groups
(Table 1). The prevalence of diabetes was significantly
higher in the expired group (P  0.01). In contrast, the
prevalence of male and polyfulfone synthetic hollow-
fiber membrane was identical between both groups.
In expired patients, a significant lower serum albumin
(P  0.01) and total cholesterol (P  0.05) was found
Table 2. Atherogenic parameters in the dead patients by
cardiovascular or noncardiovascular events
Cardiovascular Noncardiovascular P value
Number 37 14
Age years 6315 7311 0.02
Male % 54.1 71.4 NS
Time on hemodialysis
treatment years 107 138 NS
Prevalence of diabetes % 27.3 27.8 NS
Albumin g/dL 3.80.4 3.60.3 NS
Total cholesterol mg/dL 14828 13825 NS
Hemoglobin g/dL 10.01.1 9.51.1 NS
Intact PTH pg/mL 4711202 135162 NS
LDL cholesterol mg/dL 8329 8120 NS
Atherogenic index 4.21.8 2.80.9 0.02
Homocysteine lmol/L 33.118.1 37.024.9 NS
Carotid artery IMT mm 0.750.17 0.750.21 NS
Prevalence of plaque % 56.8 28.6 NS
%ACI at L2/3 38.226.5 37.024.9 NS
Ischemic ECG change % 75.0 63.6 NS
Abbreviations are: PTH, parathyroid hormone; %ACI, % aortic calcification
index; ECG, electrocardiogram; NS, not significant. Data are expressed as
mean  SD.
compared with living patients. The product of calcium
and phosphate was significantly rather lower in the dead
group (P  0.05). CRP and hemoglobin did not differ
between both groups (Table 1).
Mean carotid artery IMT was significantly larger in
the dead group compared with that in the survival group
(Table 1). A significant increase in IMT in the expired
group was also evident both in nondiabetic subjects
(0.61 0.13 mm vs. 0.74  0.19 mm, P  0.01, N  184)
and in non-smokers (0.62  0.14 mm vs. 0.74  0.16
mm, P  0.01, N  123). The prevalence of carotid
artery plaque (P  0.02) and ischemic ECG changes
(P  0.01) was significantly higher in expired patients.
In nondiabetic subjects, however, no significant differ-
ence was found in the prevalence of carotid artery plaque
in the expired group (N  35) compared with that in
the surviving group (N  149) (42.9% vs. 30.9%, P 
NS). In addition, there was no difference in maximal
plaque diameter between both groups (Table 1). A sig-
nificantly higher prevalence of ischemic ECG changes
in the dead group was also evident in non-diabetic
(67.7% vs. 34.0%, P  0.01) and in nonsmokers (80.0%
vs. 34.8%, P  0.01), respectively.
There was no significant difference in %ACI between
alive and dead subjects (Table 1). In nonsmokers, dead
patients tended to have a higher %ACI compared with
alive patients (38.6  30.8% vs. 25.9  25.7%, P  0.07).
However, in nondiabetic subjects, there was no difference
in %ACI between both groups (22.9  23.2% vs. 21.8 
20.8%, PNS). There was also no significant difference
in the prevalence of blood Hcy, LDL cholesterol, blood
pressure, and AI between two groups (Table 1).
In the dead group, expired patients by fatal cardiovas-
cular events were significantly younger than those by
noncardiovascular causes (P 0.02) (Table 2). No differ-
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Table 3. Univariate and multivariate Cox proportional hazards analysis for all-cause and cardiovascular mortality during the follow-up
Univariate Multivariate
Variable Unit RR 95% CI P value RR 95% CI P value
All-cause mortality
Age 1 year 1.06 1.04–1.09 0.01 — — —
Diabetes Referent, nondiabetes 3.49 1.99–6.12 0.01 2.88 1.46–5.61 0.01
Albumin 1 g/dL 0.14 0.05–0.40 0.01 0.22 0.06–0.73 0.01
Calcium x phosphate 0.96 0.93–0.99 0.05 — — —
IMT 0.1 mm 1.44 1.27–1.64 0.01 1.31 1.07–1.59 0.01
Plaque Referent, nonplaque 2.03 1.18–3.48 0.01 — — —
Cardiovascular mortality
Age 1 year 1.05 1.02–1.07 0.01 — — —
Diabetes Referent, nondiabetes 3.55 1.84–6.85 0.01 2.84 1.27–6.35 0.01
Albumin 1 g/dL 0.29 0.09–0.96 0.05 — — —
Intact PTH 100 pg/mL 1.03 1.00–1.06 0.03 1.05 1.02–1.08 0.01
IMT 0.1 mm 1.45 1.25–1.68 0.01 1.41 1.12–1.78 0.01
Abbreviations are: IMT, intima media thickness; PTH, parathyroid hormone.
ence was found in the prevalence of diabetes and time
on hemodialysis between two groups. AI was higher in
patients with cardiovascular death than those without
vascular accidents (P  0.02). However, there was no
difference in carotid artery IMT between both groups.
No significant difference was also found in carotid artery
plaque, %ACI, and ischemic ECG changes between two
groups (Table 2).
Impact of carotid artery IMT on 5-year survival
Univariate Cox proportional regression analysis re-
vealed that various factors such as age, diabetes, the prod-
uct of calcium and phosphorus, albumin, carotid artery
plaque, and IMT were associated with all-cause mortality
(Table 3). Similarly, age, DM, intact PTH, albumin, and
IMT were significantly related to 5-year cardiovascular
death (Table 3). In contrast, %ACI was not related to
all-cause (RR 1.01, 95% CI 1.00 to 1.02, P  0.08) and
cardiovascular mortality (RR 1.01, 95% CI 1.00 to 1.03,
P  0.09). Plasma Hcy was also not associated with all-
cause (RR 0.99, 95% CI 0.98 to 1.01, P  NS) and
cardiovascular mortality (RR 0.99, 95% CI 0.97 to 1.01,
P  NS).
Multivariate regression analysis demonstrated that di-
abetes mellitus, albumin, and carotid artery IMT became
significant independent predictors of all-cause mortality.
IMT, intact PTH, and diabetes were also indicators of
cardiovascular mortality. Adjusted hazards ratios of all-
cause and cardiovascular mortality for an increase of 0.1
mm in IMT were 1.31 (95% CI, 1.07 to 1.59) and 1.41
(95% CI, 1.12 to 1.77), respectively (P  0.01) (Table 3).
A 0.1 mm increment of IMT also increased the risk of
cardiovascular mortality by 39% (95% CI, 1.11 to 1.75)
in patients without a history of cardiovascular accidents
(N  208).
When the patients were divided into three tertiles in
relationship to IMT, Kaplan-Meier analysis revealed that
the all survival rate during 5 years was significantly lower
in the third tertile (58%, IMT  0.70 mm, N  74)
compared with that in the middle (80%, 0.55  IMT 
0.70, N 74), or in the first tertile (90%, IMT	 0.55 mm,
N  71) (P  0.01) (Fig. 2). Similarly, cardiovascular
mortality rate was significantly higher in the final tertile
(Fig. 2). In nondiabetic patients, significantly higher rates
of all-cause and cardiovascular death were also observed
in the final tertile compared to that in the first and in
the second tertile (P  0.01) (Fig. 3).
DISCUSSION
Recently, increased IMT is reported as an independent
predictor of cardiovascular events and mortality in dial-
ysis patients [17, 18]. Benedetto et al [17] first showed
that carotid artery IMT was an independent predictor
of 30-month mortality in end-stage renal failure patients
on hemodialysis or peritoneal dialysis. They demonstrated
that a 0.1 mm increment of IMT predicted a 24% higher
risk for cardiovascular mortality. Nishizawa et al [18]
also recently reported that increased IMT became an inde-
pendent predictor of 30-month cardiovascular death. In
contrast, Blacher et al [19] noticed that carotid arterial
stiffness rather than IMT is a superior predictor for car-
diovascular mortality in regular hemodialysis patients.
They also showed that calcification score at aorta, coro-
nary, femoral and common carotid arteries can be pre-
dictable of cardiovascular and all-cause mortality more
sensitively than IMT [20]. Thus, whether measurement
of carotid artery IMT is superior for predicting mortality
remains still controversy in patients with end-stage renal
failure. Since these studies followed the subjects for up to
30 months [17,18], we reexamined the impact of carotid
artery wall changes on mortality during 60 months. We
confirmed that carotid artery IMT became an indepen-
dent predictor of all-cause and cardiovascular mortality.
We also found that expired subjects had an increased
carotid artery IMT in nondiabetes mellitus or nonsmok-
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Fig. 2. Survival curves for all-cause (A ) and
cardiovascular mortality (B ) for 5 years. Pa-
tients were divided in relationship to the tertiles
of intima media thickness (IMT) (IMT	 0.55
mm, 0.55  IMT  0.70 mm, IMT  0.70
mm). A significantly lower survival rate was
found in the final tertile (P  0.01).
Fig. 3. The 5-year survival rates in nondia-
betic subjects. Patients were divided in rela-
tionship to the tertiles of intima media thick-
ness (IMT) (IMT 	 0.55 mm, 0.55  IMT 
0.70 mm, IMT 0.70 mm). Significantly lower
all-cause (A ) and cardiovascular mortality
(B ) rates were found in the first and second
tertiles compared with those in the last tertile
(P  0.01).
ing patients. In addition, increased IMT was associated
with poor prognosis in nondiabetic subjects. These find-
ings convincingly suggested that assessment of carotid
artery IMT is useful in predicting for future mortality in
uremic persons.
Arterial calcification is known to be another indepen-
dent predictor for incidental cardiovascular events in
general population [21–23]. In the Framingham Heart
Study, abdominal aortic calcific deposits are associated
with increased risks for congestive heart failure [22], and
vascular morbidity and mortality [23]. Calcification of
the aortic arch is also related to future coronary heart
disease, stroke, and peripheral vascular disease [24]. In
hemodialysis patients, the presence and extent of arterial
calcifications at large arteries are demonstrated as a pre-
dictor of cardiovascular mortality [20]. The product of
calcium and phosphate, an important factor associated
with calcification of the abdominal aorta [25], is also an
independent risk factor for cardiovascular death [26]. In
the present study, however, univariate regression analy-
sis failed to show any significant association between
aortic wall calcification and mortality. The reasons for
this minor contribution of aortic calcific deposit are un-
known, but may be partly due to our shorter observation
time and analytic methods. In Framingham Heart Study
[23], the impact of increased abdominal aortic calcifica-
tion on cardiovascular death became obvious over 12-
year follow-up. Furthermore, heritable factors play a
role in the presence and extension of abdominal aortic
calcification in general subjects [27]. Interestingly, in-
creased aortic pulse wave velocity (PWV), a marker of
aortic stiffening, is shown as an independent predictor
of mortality in hemodialysis patients [28, 29]. Insensitiv-
ity of PWV in response to decreases in blood pressure
is also an independent predictor of mortality in dialysis
subjects [30]. Because PWV is associated with the extent
of elastic-type arterial calcification [28, 31], comeasure-
ment of aortic PWV will more clarify a possible role of
aortic wall calcification for future death in hemodialysis
subjects. In addition, recently available higher-resolution
axial CT would be expected to provide more reproduc-
ible and quantitative estimates of aortic calcific deposits.
Hyperhomocysteinemia is frequently found in dialysis
subjects and has demonstrated as a potent indicator of
mortality in the previous studies [18, 32, 33]. In this study,
however, we did not find any association between plasma
total Hcy and cardiovascular and all-cause mortality. The
reasons for this minor role of Hcy remain unknown,
but may be partly due to well nutritional status in our
patients. Median serum albumin was 4.0 g/dL, and only
25 patients (11.4%) had a lower serum albumin below
3.5 g/dL in this study. Serum albumin is the main carrier
of circulating Hcy. Blood total Hcy level is strongly re-
lated to serum albumin, nutritional status, and dietary
protein intake in hemodialysis subjects [34], indicating
that well-preserved nutritional status may influence the
impact of Hcy on mortality. In addition, our study may
not have enough population to demonstrate the effect
of Hcy on mortality.
Long-standing inflammation, malnutrition, and oxida-
Kato et al: Carotid artery intima-media thickening and mortality in HD patients1478
tive stress are known to be associated with accelerated
atherosclerosis in patients with end-stage renal failure
[35, 36]. Age, systemic blood pressure, and smoking were
correlated independently with carotid artery IMT [33].
However, in this study, only normal aging became a deter-
minant of IMT among traditional risk factors. In contrast,
blood albumin, total cholesterol and CRP were signifi-
cantly correlated with log IMT. We found that low choles-
terolemia was an indicator of IMT, confirming a possible
role of malnutrition and/or inflammation for accelerated
arterial thickening in hemodialysis patients [13].
We found that elevated intact PTH became another
independent predictor of cardiovascular mortality in our
patients. IMT tended to be higher in the dead group com-
pared with that in the alive group (P  0.06) (Table 1).
Intact PTH is reported to be associated with carotid artery
IMT in patients with primary and secondary hyperpara-
thyroidism [37, 38]. However, in this study, intact PTH
was not related to IMT and %ACI, indicating that eleva-
tions in PTH was not associated with arterial thickening
and calcification in large-sized vessels. Additional studies
will be needed to examine that increased PTH may affect
small-sized arterial vascular tone and/or cardiac function
via an increase in the intracellular calcium concentration.
In this study, IMT became a significant predictor of
overall death, a similar finding with a previous study [19].
In addition, atherogenic parameters did not differ be-
tween patients who died of cardiovascular causes and
those who did not have fatal cardiovascular events, prob-
ably due to older population in the noncardiovascular
fatal group (mean age, 63 years vs. 73 years). We con-
firmed a significant increase in carotid artery IMT in age-
matched subjects with cardiovascular death (mean age,
74 years, N  14) compared to those without cardiovas-
cular death (N  14) (0.90  0.13 mm vs. 0.75  0.21
mm, P  0.04).
There are some limitations in this study. First, we
did not measure carotid arterial stiffening. Second, we
semiquantitatively evaluated vascular calcification only
at abdominal aorta, since assessment of coronary artery
calcification was inaccurate by CT scan. Recently, elec-
tron beam tomography (EBT) is used as a noninvasive
method directly to measure coronary calcium content.
A high calcium score at coronary arteries on EBT im-
aging is indicative for myocardial infarction and coronary
death in middle-aged general subjects [39]. Thus, EBT
measurement will clarify the prognostic values of coro-
nary plaque calcification in dialysis patients. Finally, we
could not define abnormal IMT and %ACI in this study,
since we did not examine these parameters in age- and
gender-matched healthy population. Different imaging
protocols and/or races also failed to take referred control
values from literature [3–9].
Although it became clear that carotid artery IMT is
a good predictor of subsequent mortality in hemodialysis
persons, differing imaging protocols were used in the
various trials, making comparison of the results unneces-
sarily confusing in dialysis subjects. For example, we fo-
cused mainly on the near wall of common carotid artery,
and calculated its mean value, while another study [5]
included bulb, internal and external arteries, and used
their greatest IMTs for analysis. Furthermore, focal plaque
is commonly found in internal carotid artery but seldom
in common carotid artery [1]. Thus, further trials will be
needed to establish a standardized protocol and consen-
sus to facilitate comparison of results among the many
studies using this technique.
CONCLUSION
We showed that increased carotid artery IMT portends
a significantly higher risk of all-cause and cardiovascular
death in hemodialysis patients. A 0.1 mm increment of
carotid artery IMT was associated with 31% and 41%
increased risks for all-cause and cardiovascular 5-year
mortality, respectively. Recently, clinical trials by cal-
cium antagonists [40] and antibiotics [41] are reported
to regress progression of carotid artery IMT in general
subjects. Thus, additional studies will be needed to ascer-
tain that slowing incremental value of carotid artery IMT
by pharmacologic agents may be a predictor of survival
in dialysis subjects.
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